DeviceTalks Podcast Network

This week’s episode is dedicated entirely to the 10 Finalists of MedTech Innovator’s Pitch Competitions. The final winners will be selected by the audience on Oct. 10 at the upcoming AdvaMed annual meeting.

The finalists for MedTech Innovator’s grand prize of $350,000 are listed below. Click on the link to watch their 1-minute pitch video.

Dr. Tom McClellan - Fingy3D - https://www.youtube.com/watch?v=KCoj_ZALf3c

Amanda French - IFPx - https://www.youtube.com/watch?v=8B3j2weOkNo

Jay Shah/Vivek Ganesh - Neurava - https://www.youtube.com/watch?v=lyUB9WCLeww

Dr. Alex Woods - Newrotex - https://www.youtube.com/watch?v=MEhP_Ack32c

Alex Ballatori/Shane Shahrestani - StrokeDx - https://www.youtube.com/watch?v=tdkl5QyDfD8

The companies listed below are vying for MedTech Innovator’s Execution Award. The winner will receive $25,000. Click on the link to watch their 1-minute pitch video.

Harlee Sorkin - InterShunt Technologies - https://www.youtube.com/watch?v=QPi5FSRSjUQ

Michael Ebner - Hypervision Surgical - https://www.youtube.com/watch?v=oTz-AXfwJgw

Lori Arakaki - Opticyte - https://www.youtube.com/watch?v=AECmlLpv0hE

Joanna Nathan - Prana Thoracic - https://www.youtube.com/watch?v=myjUp3Gg4mQ

Dushyanth Surakanti - Sparta Biomedical - https://www.youtube.com/watch?v=wvS9PwpkT_c

DeviceTalks’s Tom Salemi and Kayleen Brown visited with the founders and CEOs of each of the 10 companies. We’ll run through those interviews with Paul Grand, CEO of the MedTech Innovator program.

Thanks for listening to the DeviceTalks Weekly Podcast

Subscribe to the DeviceTalks Podcast Network on any major podcast application.

In the newest episode of AbbottTalks, Ryan Lakin, Divisional Vice President of Digital Solutions, Medical Devices at Abbott, delves deep into the transformative role of digital health solutions in the medical device landscape and emphasizes Abbott's commitment to not just treating the sick but also empowering individuals to maintain optimal health.

Lakin shares insights into how Abbott's innovative technologies, like the FreeStyle Libre 2 glucose monitoring system and Lingo, are reshaping patient care by offering real-time data and insights. This proactive approach allows patients to understand their body's reactions to various stimuli, leading to more informed health decisions.

Lakin also touches on the challenges of integrating digital tools into healthcare, highlighting the need for evidence-based solutions that genuinely add value. He underscores the importance of simplifying patient pathways, reducing healthcare worker burdens, and enhancing overall patient experiences. As Abbott continues to pioneer in this realm, Lakin speaks to a future where medical devices play a more holistic role in patient care, from prevention to intervention. Listen today to hear more on how Abbott is shaping the future of digital health.

Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.

Thank you for listening to the AbbottTalks Podcast.

Osteoarthritis isn’t a typical target for startups but Moximed isn’t developing a typical device. In this episode, CEO Anton Clifford will walk us through the biomedical process that led to the decision to build a shock absorber that can stabilized an injured knee. The route been long, winding and has led the team over some bumpy roads but Moximed is poised to deliver on its long-time promise.

At the start,co-hosts Tom Salemi and Chris Newmarker chat with Associate Editor Sean Whooley about Boston Scientific’s recent analyst day, with a tight focus on why Boston Scientific sees opportunity in China when other medical devices are withdrawing.

Notes for this episode

https://www.massdevice.com/boston-scientific-targets-next-level/

https://www.medicaldesignandoutsourcing.com/china-exposure-medtronic-intuitive-henry-schein-align-envista-dentsply-sirona/

https://www.massdevice.com/zimvie-reports-difficult-macroenvironment-q4-miss/

https://www.massdevice.com/category/massdevice-podcast/

Thanks for listening to the DeviceTalks Weekly Podcast

Subscribe to the DeviceTalks Podcast Network on any major podcast player.

In this episode of IntuitiveTalks, Tony Jarc, Sr. Director of Digital & Machine Learning at Intuitive, walks us through the evolving landscape of surgical robotics, highlighting the transformative potential of AI and machine learning in enhancing surgical procedures, providing real-time guidance to ensure the best possible patient outcomes.

Jarc also introduces Case Insights enabled by the My Intuitive hub, a digital tool designed to offer surgeons valuable post-operative feedback. But the platform's potential goes beyond the data.

Jarc also underscores the significance of collaborating with surgeons from the early stages of product development to ensure its useability and effectiveness. As surgical robotics continue to advance, Jarc's insights provide a glimpse into how technology and human expertise can work in tandem for improved surgical procedures. Listen now to learn more about how Intuitive is not just embracing the intersection of AI and surgical robotics but using it to guide future opportunities.

Thank you to TECAN, for sponsoring this episode of IntuitiveTalks. Visit tecan.com/paramit-design-to-manufacturing to hear from TECAN’s leadership team in an expert video series and to download TECAN’s Product Requirements Checklist to help you prepare for your product development.

Thank you for listening to the IntuitiveTalks Podcast.

Subscribe to this podcast on every major podcast platform.

This week we’ll visit with Daniel Hawkins, CEO of Avail Medsystems. Hawkins is a prolific and successful medtech entrepreneur who was an early employee at Intuitive and co-founder of Shockwave Medical. Hawkins talks about both experiences, but DeviceTalks listeners should listen carefully for his insights on how ASCs are changing medtech and how OEMs are using Avail’s telepresence system to compensate.

DeviceTalks Editorial Director Tom Salemi and Managing Editor Kayleen Brown share their takeways from the MedtechVISION conference in Menlo Park. The conference raised many themes that we’ll be exploring at DeviceTalks West on October 18-19 at the Santa Clara Convention Center.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on many major podcast player.

In this week’s episode, medical device pro Kurt Haggstrom details what led him to join high-flying neural implant company Synchron, which is one of the companies in a supposed race to create a direct link to the brain. Haggstrom will be sharing even more details at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center. But today’s episode will give a sample of why he sees Synchron changing the world as it works to unlock “the natural highways of the brain.” We’ll also talk about the value of good engineering and marketing in medical devices. Find out more about Synchron here. https://synchron.com/

Executive editor Chris Newmarker joins us to discuss this week’s news that Philips reached a partial settlement in its class-action suit over sleep apnea machine recall. This isn’t the end of the story. To read all about the recall go here. https://www.massdevice.com/how-philips-significant-respiratory-devices-recall-unfolded/

Thanks for listening to the DeviceTalks Weekly Podcast.

You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

This isn’t Bertin Nahum’s first surgical robotics rodeo. The CEO of Quantum Surgical previously co-founded, led and ultimately sold surgical robotics pioneer Medtech S.A. to Zimmer Biomet. Now, he’s leading several members of that founding team as Quantum Surgical develops a next generation of surgical robot to enable easier removal of cancerous tumors. Nahum brings great insight and perspective to the topic of surgical robotics, which is why he’ll sit on a panel of surgical robotic company CEOs and provider represents to discuss what surgical robotic systems of the future may look like. Register at DeviceTalks.com.

Joining co-hosts Chris Newmarker and Tom Salemi is Danielle Kirsh, senior editor of MassDevice, to review a few of the highpoints of the current Medical Design and Outsourcing issue of the Big 100. We’ll talk about headcounts, R&D spends and CEO salaries. You can find the issue of the Big 100 here. https://www.medicaldesignandoutsourcing.com/september-2023-medtech-big-100-largest-device-companies/

Thanks for listening to the DeviceTalks Weekly Podcast.

You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this episode of StrykerTalks, Andrés Rosales, VP and General Manager Endoscopy, delves into Stryker's groundbreaking 1788 visualization platform and and its potential to revolutionize surgical procedures. The 1788 visualization platform, Stryker's 26th generation camera, enables surgeons to see more so they can do more by visualizing tissue perfusion and illuminating cancer cells, ultimately improving patient outcomes.

Rosales also discusses the newly 510(k) cleared SPY-PHI for lymphatic mapping within breast cancer, offering surgeons a more efficient and patient-friendly alternative to traditional radioactive markers.

The innovation continues as Rosales hints at the future of Stryker's technology, emphasizing the role of data collection and algorithm development in improving surgical procedures.

Tune in to discover how Stryker is setting new standards in surgical visualization and how Stryker is collaborating with customers to create meaningful tools that improve the patient experience.

Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.

Thank you for listening to the StrykerTalks Podcast.

Subscribe to this podcast on every major podcast platform

In this week’s podcast, we’ll visit with John McCutcheon, president and CEO of EBR Systems, which is developing a miniature pacemaker that is powered by ultrasound and located in the left ventricle of the heart. McCutcheon shares his plans for the start-up but more on the point of this week he recalls his experience as CEO of Emphasys Medical, an interventional pulmonology start-up that received a shocking negative recommendation from an FDA panel in 2008. The no vote led to the shutdown and sale of Emphasys, but the rejection ultimately helped convince the FDA and industry to assess their relationship. Ultimately, the two sides improved relations as McCutcheon explains in the podcast. The rejection is somewhat reminiscent of the negative vote issued this week by an advisory panel for Medtronic’s Symplicity Spyral renal denervation (RDN) therapy for hypertension. McCutcheon explains how the negative impact impacted him at the time, but more important how he’s moved on to appreciate the experience.

Thanks for listening to the DeviceTalks Podcast Network.

Subscribe to the DeviceTalks Podcast Network on any major podcast application.

In the newest episode of AbbottTalks, Vish Charan, divisional VP of product development at Abbott, takes us through the inner workings of the recently FDA-approved AVEIR™ DR Dual Chamber Leadless Pacemaker System, from its inception to its successful clinical trial and FDA approval.

Charan also dives deep into the technology, revealing the cutting-edge i2i communication technology that powers AVEIR™ pacemakers, enabling seamless communication between devices for dual chamber pacing and AV synchrony.

Finally, Charan discusses the challenges of miniaturization, the remarkable advancements in battery technology that have made the AVEIR™ pacemaker possible, and the potential for further applications in conduction system pacing.

As the field of cardiac rhythm management continues to evolve, Charan envisions a future of smaller devices, more features, and enhanced patient care. Make sure to listen in for invaluable insights into the groundbreaking AVEIR™ DR and its potential to transform the landscape of cardiac care.

Thank you to Resonant Link for sponsoring this episode of AbbottTalks. For more information about Resonant Link go to www.Resonant-Link.com.

Thank you for listening to the AbbottTalks Podcast.